You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In PNAS this week: concerns regarding proposed SARS-CoV-2 phylogenetic network, adaptations that help Enterococcus establish infections, and more.
In PLOS this week: gene alteration linked to glaucoma, genome sequencing traces origin of lager yeast, and more.
In Genome Biology this week: computational approach to determine phylogenetic relationships from single-cell data, metagenomic classification pipeline, and more.
Independent teams reported on apparent SARS-CoV-2 transmission events in China's Guangdong province and in Connecticut, using genome sequence, travel, and epidemiology data.
Researchers have been using Nextstrain, which includes data for thousands of SARS-CoV-2 genomes, to study how the virus accrues mutations over time.
A sequencing analysis led by researchers at Shantou University in China provides evidence that pangolins may be an intermediary host for SARS-CoV-2.
Bloomberg writes that Fred Hutchinson Cancer Research Center's Trevor Bedford and his colleagues continue to use viral genomics to track SARS-CoV-2.
Chinese researchers conducted a systematic comparison between the newly discovered coronavirus genome and SARS-like viruses that caused previous epidemics.
In PLOS this week: role for TWIST1 gene expression in vascular disease risk, new Campylobacter species, and more.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.
Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.
Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.
A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.
In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.